|
Report No. : |
353531 |
|
Report Date : |
04.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
AMCO
INCORPORATED |
|
|
|
|
Registered Office : |
4-8-7 Iidabashi Chiyodaku Tokyo 102-0072 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.07.2015 |
|
|
|
|
Date of Incorporation : |
Jan., 1951 |
|
|
|
|
Com. Reg. No.: |
0100-01-010255 (Tokyo-Chiyodaku) |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import and Wholesale of Medical Devices, Scientific Instruments. |
|
|
|
|
No. of Employees : |
150 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
JAPAN - ECONOMIC
OVERVIEW
In the years following World War II, government-industry
cooperation, a strong work ethic, mastery of high technology, and a
comparatively small defense allocation (1% of GDP) helped Japan develop an
advanced economy. Two notable characteristics of the post-war economy were the
close interlocking structures of manufacturers, suppliers, and distributors,
known as keiretsu, and the guarantee of lifetime employment for a substantial
portion of the urban labor force. Both features are now eroding under the dual
pressures of global competition and domestic demographic change. Scarce in many
natural resources, Japan has long been dependent on imported raw materials.
Since the complete shutdown of Japan’s nuclear reactors after the earthquake
and tsunami disaster in 2011, Japan's industrial sector has become even more
dependent than it was previously on imported fossil fuels. A small agricultural
sector is highly subsidized and protected, with crop yields among the highest
in the world. While self-sufficient in rice production, Japan imports about 60%
of its food on a caloric basis. For three decades, overall real economic growth
had been impressive - a 10% average in the 1960s, a 5% average in the 1970s,
and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging
just 1.7%, largely because of the aftereffects of inefficient investment and an
asset price bubble in the late 1980s that required a protracted period of time
for firms to reduce excess debt, capital, and labor. Modest economic growth continued
after 2000, but the economy has fallen into recession four times since 2008.
Government stimulus spending helped the economy recover in late 2009 and 2010,
but the economy contracted again in 2011 as the massive 9.0 magnitude
earthquake and the ensuing tsunami in March of that year disrupted
manufacturing. The economy has largely recovered in the four years since the
disaster, although reconstruction in the affected Tohoku region has lagged, in
part due to a shortage of labor in the construction sector. Japan enjoyed a
sharp uptick in growth in 2013 on the basis of Prime Minister Shinzo Abe’s
“Three Arrows” economic revitalization agenda - dubbed “Abenomics” - of
monetary easing, “flexible” fiscal policy, and structural reform. Abe’s
government has replaced the preceding administration’s plan to phase out
nuclear power with a new policy of seeking to restart nuclear power plants that
meet strict new safety standards, and emphasizing nuclear energy’s importance
as a base-load electricity source. Japan joined the Trans-Pacific Partnership
(TPP) negotiations in 2013, a pact that would open Japan's economy to increased
foreign competition and create new export opportunities for Japanese
businesses. Measured on a purchasing power parity (PPP) basis that adjusts for
price differences, Japan in 2014 stood as the fourth-largest economy in the
world after first-place China, which surpassed Japan in 2001, and third-place
India, which edged out Japan in 2012. While seeking to stimulate and reform the
economy, the government must also devise a strategy for reining in Japan's huge
government debt, which amounts to more than 230% of GDP. To help raise
government revenue, Japan adopted legislation in 2012 to gradually raise the
consumption tax rate to 10% by 2015, beginning with a hike from 5% to 8%
implemented in April 2014. That increase had a contractionary effect on GDP,
however, so PM Abe in late 2014 decided to postpone the final phase of the
increase until April 2017 to give the economy more time to recover. Led by the
Bank of Japan’s aggressive monetary easing, Japan is making progress in ending
deflation, but demographics - low birthrate and an aging, shrinking population
- pose major long-term challenges for the economy.
|
Source
: CIA |
AMCO INCORPORATED
REGD NAME: KK
Amco
MAIN OFFICE: 4-8-7
Iidabashi Chiyodaku Tokyo 102-0072 JAPAN
Tel: 03-3265-4262 Fax: 03-3265-4271
URL: http//:www.amco.co.jp
E-mail: info@amco.co.jp
Import, wholesale of
medical devices, scientific instruments
Osaka, Nagoya,
Fukuoka, Sapporo, Sendai, Hiroshima
AKIHIRO KOSHIKAWA,
PRES Teruo Hayashi, dir
Kenzo Watanabe,
dir Morio Yamazaki, dir
Toru Hiroishi, dir
Yen Amount: In million Yen, unless otherwise stated
FINANCES FAIR A/SALES Yen 8,979 M
PAYMENTSNO COMPLAINTS CAPITAL Yen 84 M
TREND STEADY WORTH Yen 6,903 M
STARTED 1951 EMPLOYES 150
TRADING FIRM
SPECIALIZING IN MEDICAL & SCIENTIFIC DEVICES.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD
FOR ORDINARY BUSINESS ENGAGEMENTS.
The subject
company was established by father of Yoichiro Sakata for importing medical
devices from USA. This is a trading firm
specializing in importing and wholesaling medical devices & diagnostics,
scientific equipment & devices, other (See OPERATION). In 1967 imported
artificial kidney apparatus for
the first time in Japan. Goods are imported from USA, Germany, other. Clients include public hospitals, university
hospitals, municipal hospitals,
other, nationwide. 6 branch offices cover the domestic markets.
The sales volume
for July/2014 fiscal term amounted to Yen 8,979 million, a 1% up from Yen 8,867
million in the previous term. The recurring
profit was posted at Yen 2,152 million and the net profit at Yen 558 million,
respectively, compared with Yen 1,997 million recurring profit and Yen 524
million net profit, respectively, a year ago.
For the term that
ended July 2015 the recurring profit was projected at Yen 2,260 million and the
net profit at Yen 585 million, respectively, on a 5% rise in turnover, to Yen
9,425 million. The weaker Yen may have contributed to raise earnings in Yen terms. Final results are
not yet to be released.
The financial
situation is considered FAIR and good for ORDINARY business engagements.
Date Registered: Jan
1951
Regd No.:
0100-01-010255
(Tokyo-Chiyodaku)
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 3.6 million shares
Issued: ,684,800 shares
Sum: Yen 84.24 million
Major
shareholders (%): Yoichiro Iida (14.7),
Akihiro Koshikawa (10), Seiji Yamada (10), Kimiyoshi Aizawa (8.7)
No. of shareholders: 30
Nothing detrimental
is known as to the commercial morality of executives.
Activities: Imports and
wholesales medical devices & diagnostics (80%), scientific equipment &
devices, other (20%). (% is all about)
Medical devices
& diagnostics: cautery knife, organ plasma coagulator, operating
table, full automatic aeroperitoria device, forceps, endoscope, trocal canula,
headlight system, blood collecting device, osmometer, organs preservation
facility, ECG electrode, blood pressure gauge, hemoglobin locator, pulse
oximeter, MDI spacer, urination measuring instrument, fiberscope trocar, urine
collector, headlight system, balloon dilator, other;
Scientific
devices/equipment: elemental analyzer, full automatic microgen/protein
identificator, surface area measuring device, ultrasonic level meter, field
fluorescent photometer, bacteriopexy system, microbiogical accuracy control
system, analrobic culture chamber system, sterilization indicator, scanalyzer,
imaging flowcytmeter, environmental instruments, other. ,
Clients: [Mfrs,
wholesalers] Mutoh Group, Miyano Medical Instruments, Yagami Co, Kyowa Medical
Holdings, other
No. of accounts: 500
Domestic areas of activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Elbe, Konica Minolta, Fresenius Medical Care Japan, Integra,
Steris Japan, Alpen Japan, Boston Scientific, Cobe Laboratories, Puritan
Benette, Vitek Systems, other
Payment
record: No Complaints
Location: Business area in Tokyo. Office premises at the caption address are leased
and maintained satisfactorily.
Bank References:
Mizuho Bank (Iidabashi)
SMBC (Ueno)
Relations: Satisfactory
(In
Million Yen)
|
Terms Ending: |
31/07/2015 |
31/07/2014 |
31/07/2013 |
31/03/2012 |
|
|
Annual
Sales |
|
9,425 |
8,979 |
8,867 |
8,098 |
|
Recur.
Profit |
|
2,260 |
2,152 |
1,997 |
1,694 |
|
Net
Profit |
|
585 |
558 |
524 |
342 |
|
Total
Assets |
|
|
10,428 |
9,247 |
7,674 |
|
Current
Assets |
|
|
8,689 |
7,720 |
6,259 |
|
Current
Liabs |
|
|
2,049 |
2,117 |
1,626 |
|
Net
Worth |
|
|
6,903 |
5,579 |
4,479 |
|
Capital,
Paid-Up |
|
|
84 |
84 |
84 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
4.97 |
1.26 |
9.50 |
4.94 |
|
Current Ratio |
|
.. |
424.06 |
364.67 |
384.93 |
|
N.Worth Ratio |
|
.. |
66.20 |
60.33 |
58.37 |
|
R.Profit/Sales |
|
23.98 |
23.97 |
22.52 |
20.92 |
|
N.Profit/Sales |
|
6.21 |
6.21 |
5.91 |
4.22 |
|
Return On Equity |
|
.. |
8.08 |
9.39 |
7.64 |
Notes: Forecast
(or estimated) figures for the 31/07/2015 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.75 |
|
|
1 |
Rs.99.61 |
|
Euro |
1 |
Rs.70.67 |
|
Yen |
1 |
Rs.0.55 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
KIN |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.